Table 2.
Half‐maximal inhibitory concentration for mitomycin C and oxaliplatin by organoid line
| Organoid line | IC50 (μmol/l) | |
|---|---|---|
| Mitomycin C | Oxaliplatin | |
| TOR 14 | 3·3 (2·3, 4·6) | 368 (326, 414) |
| TOR17 | 12·9 (15·5, 30·9) | 692 (375, 1277) |
| TOR22 | 7·4 (4·4, 12·5) | 364 (243, 544) |
| TOR10MII | 5·6 (4·7, 6·6) | 297 (253, 348) |
| P02‐1 | 22·2 (10·8, 45·5) | 549 (449, 672) |
Estimated half‐maximal inhibitory concentrations (IC50) were pooled over all batches using a non‐linear mixed‐effect model. Values in parentheses are 95 per cent confidence intervals.